Happydreamer
12.5K posts

Happydreamer
@Watermelon0908
God Bless America! Trump won 2020!Trump won 2024!!!

BREAKING: Largest Human Cancer Study of Ivermectin + Mebendazole Is Now PEER-REVIEWED and PUBLISHED in a MAJOR Cancer Journal 84.4% of cancer patients taking ivermectin + mebendazole for 6 months declared either CANCER DISAPPEARANCE, TUMOR REGRESSION, or CANCER STABILIZATION. Our study, “Real-world Clinical Outcomes of Ivermectin and Mebendazole in Cancer Patients: Results from a Prospective Observational Cohort,” is now peer-reviewed and published in Anticancer Research—a major international oncology journal of the International Institute of Anticancer Research (IIAR), established in 1995. The results represent one of the most compelling clinical signals ever documented for repurposed anti-parasitic therapies in oncology. A diverse population of cancer patients (n=197) was prescribed compounded ivermectin–mebendazole through a U.S. telemedicine platform, with each capsule containing 25 mg ivermectin and 250 mg mebendazole. Participants were followed for approximately six months using standardized digital surveys assessing cancer outcomes, medication adherence, and tolerability. At approximately six months post-treatment initiation, we observed an 84.4% Clinical Benefit Ratio (CBR)—meaning more than four out of five patients reported either: No evidence of disease (32.8%) Tumor regression (15.6%) or Cancer stabilization (36.1%) Importantly, adherence was remarkably high, with 86.9% completing the initial prescription and 66.4% remaining on therapy at six months. Side effects were predominantly mild and manageable, reported in 25.4% of patients (primarily gastrointestinal), with 93.6% of those experiencing side effects continuing treatment after minor dosing adjustments. This groundbreaking peer-reviewed publication was made possible through a unique collaboration between The Wellness Company, the McCullough Foundation, and the Chairman of the President’s Cancer Panel—uniting real-world clinical data, frontline medical experience, and epidemiologic expertise to evaluate inexpensive, repurposed therapies with major translational potential. With these extraordinarily promising results, double-blind, placebo-controlled clinical trials are now required. In the meantime, many cancer patients are exercising their right to try. @twc_health @McCulloughFund @IIAR_Journals @P_McCulloughMD @DrHarveyRisch @DrKellyVictory @jathorpmfm @drdrew @PeterGillooly @FosterCoulson


Claude just dropped 13 FREE AI courses (with certificates). No $500 course needed. No “guru” required. Just real skills — straight from Anthropic. Here’s the full list: 👇 1. Claude 101 lnkd.in/gCPUQsRg 2. AI Fluency: Frameworks & Foundations lnkd.in/gS6ceZ_M 3. Introduction to Agent Skills lnkd.in/g_wWNiEb 4. Building with the Claude API lnkd.in/gDr5K_B4 5. Claude Code in Action lnkd.in/g9wWZbK9 6. Introduction to Model Context Protocol lnkd.in/gAj5HqMY 7. MCP: Advanced Topics lnkd.in/g3eDwBFY 8. AI Fluency for Students lnkd.in/gKKujHGG 9. AI Fluency for Educators lnkd.in/gVcKnuhA 10. Teaching AI Fluency lnkd.in/g9P4gJFM 11. AI Fluency for Nonprofits lnkd.in/gpsm_BVf 12. Claude with Amazon Bedrock lnkd.in/gbfPjSFt 13. Claude with Google Vertex AI lnkd.in/gvVgB4Ub — If you go through even HALF of these… You’ll be ahead of 95% of people using AI. Most people won’t. Because they’re still: • Watching random YouTube videos • Buying overpriced courses • “Learning AI” without actually building Don’t be that person. Do this instead: 1. Save this post (you’ll come back to it) 2. Pick 1 course → start today 3. Share it with someone who needs this Free. Practical. No excuses.























